Back to Top
Go Back
Journal Photo for Science Translational Medicine
Peer reviewed only Open Access

Science Translational Medicine (STM)

Publisher : American Association for the Advancement of Science
Medicine
Claim Your Journal Get PRC Visit Website
e-ISSN 1946-6242
p-ISSN 1946-6234
Issue Frequency weekly
Est. Year 2009
Mobile 12023266501
Country United States
Language English
APC YES
Impact Factor Assignee Google Scholar
Email scitranslmededitors@aaas.org

Journal Descriptions

Science Translational Medicine is the leading weekly online journal publishing translational research at the intersection of science, engineering and medicine. The goal of Science Translational Medicine is to promote human health by providing a forum for communicating the latest research advances from biomedical, translational, and clinical researchers from all established and emerging disciplines relevant to medicine. In addition to original research, Science Translational Medicine also publishes Reviews, Editorials, Focus articles, and Viewpoints. Science Translational Medicine is the leading weekly online journal publishing research at the intersection of science, engineering and medicine. The goal of Science Translational Medicine is to promote human health by providing a forum for communicating the latest research advances from biomedical, translational, and clinical researchers from all established and emerging disciplines relevant to medicine. Despite 50 years of progress in our fundamental understanding of human biology and the emergence of powerful new technologies, the translation of this knowledge into effective new treatments and health measures has been slow. Science Translational Medicine seeks to publish articles that fill the scientific knowledge gaps at the junction of preclinical research and medical applications in order to accelerate the translation of this knowledge into new ways for preventing, diagnosing and treating human disease.

Science Translational Medicine (STM) is :-

  • International, Peer-Reviewed, Open Access, Refereed, Medicine , Online or Print , weekly Journal

  • UGC Approved, ISSN Approved: P-ISSN P-ISSN: 1946-6234, E-ISSN: 1946-6242, Established: 2009,
  • Does Not Provide Crossref DOI

  • Indexed in: Scopus

  • Not indexed in WoS, DOAJ, PubMed, UGC CARE

Indexing

Publications of STM

Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
Bert Vogelstein December, 2014
Cancer evolves over time, without any warning signs. Similarly, the development of resistance to therapy generally becomes apparent only when there are obvious signs of tumor growth, at whic...
Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer
Bert Vogelstein July, 2016
Stage II colon cancer, which has spread through the wall of the colon but has not metastasized to the lymph nodes, can present a therapeutic dilemma. On one hand, these tumors can usually be...
Recurrent GNAS Mutations Define an Unexpected Pathway for Pancreatic Cyst Development
Bert Vogelstein
More than 2% of the adult U.S. population harbors a pancreatic cyst. These often pose a difficult management problem because conventional criteria cannot always distinguish cysts with malign...
Detection of Chromosomal Alterations in the Circulation of Cancer Patients with Whole-Genome Sequencing
Bert Vogelstein November, 2012
Clinical management of cancer patients could be improved through the development of noninvasive approaches for the detection of incipient, residual, and recurrent tumors. We describe an appr...
Development of Personalized Tumor Biomarkers Using Massively Parallel Sequencing
Bert Vogelstein February, 2010
Clinical management of human cancer is dependent on the accurate monitoring of residual and recurrent tumors. The evaluation of patient-specific translocations in leukemias and lymphomas has...
Detection of somatic mutations and HPV in the saliva and plasma of patients with head and neck squamous cell carcinomas
Bert Vogelstein June, 2015
To explore the potential of tumor-specific DNA as a biomarker for head and neck squamous cell carcinomas (HNSCC), we queried DNA from saliva or plasma of 93 HNSCC patients. We searched for s...